Rectal administration of nicomorphine in patients improves biological availability of morphine and its glucuronide conjugates
- 32 Downloads
The pharmacokinetics of 30 mg nicomorphine after rectal administration with a suppository are described in 8 patients under combined general and epidural anaesthesia. No nicomorphine or 6-mononicotinoylmorphine could be detected in the serum. Morphine appeared almost instantaneously with a lag-time of 8 min and had a final elimination half-life of 1.48±0.48 h. Morphine was metabolized to morphine-3-glucuronide and morphine-6-glucuronide. These glucuronide conjugates appeared after a lag-time of 12 min and the half-life of these two glucuronide conjugates was similar: about 2.8 h (P>0.8). The glucuronide conjugate of 6-mononicotinoylmorphine was not detected. In the urine only morphine and its glucuronides were found. The renal clearance value for morphine was 162 m·min−1 and for the glucuronides 81 ml·min−1. This study shows that administration of a suppository with 30 mg nicomorphine gives an excellent absolute bioavailability of morphine and its metabolites of 88%. The lipid-soluble prodrug nicomorphine is quickly absorbed and immediately hydrolysed to morphine.
KeywordsAdministration, rectal Anesthesia Biological availability Chromatography, high pressure liquid Metabolites Nicomorphine Pharmacokinetics
Unable to display preview. Download preview PDF.
- 1.Dirksen R, Van de Pol F, Nijhuis GMM. Mechanisms of effectiveness of intravenous nicomorphine and its hydrolysis products in rats. In: Kopera H, Booy LHDJ, editors. Proceedings of the Vilan® workshop; Graz 1987; 1988:10–6.Google Scholar
- 2.Pinckaers JWM, Nijhuis GMM, Dirksen R. Postoperative nicomorphine analgesia by spinal or epidural application. Anesth Intensivmed 1982;152:16–24.Google Scholar
- 16.Hanna MH, Peat SJ, Knibb A, Fung C. Disposition of morphine-6-glucuronide and morphine in healthy volunteers. Br J Anaest 1991;66:103–7.Google Scholar
- 22.D'Honneur G, Gilton A, Sandouk P, Scherrmann JM, Duvaldestin P. Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine. Anaesthesiology 1994;81:87–93.Google Scholar
- 25.Iwamoto K, Klaassen CD. First pass effect of morphine in rats. J Pharm Exp Ther 1977;200:236–44.Google Scholar
- 26.Koopman-Kimenai PM, Vree TB, Booij LHDJ, Dirksen R. Pharmacokinetics of intravenously administered nicomorphine and its metabolites and glucuronide conjugates in surgical patients. Drug Invest 1994;7:63–73.Google Scholar
- 33.Moolenaar F, Leuverman A, Schoonen BJM. Bioavailability of morphine from suppositories. Int J Pharm 1988;45:161–4.Google Scholar
- 34.Greven J. Renal transport of drugs. In: Greger R, Lang F, Silbernagl S, editors. Renal transport of organic substances. Berlin: Springer Verlag, 1981:262–77.Google Scholar
- 39.Patel N, Joel SP, Lam W, Slevin ML. Is morphine-3,6-diglucuronide an important metabolite of morphine or morphine-6-glucuronide? [abstract]. 7th World Congress on Pain; 1993 Aug 22–27; Paris. Seattle: IASP Publications, 1993;530:1405.Google Scholar